公司資料

Abeona Therapeutics 股價、新聞與催化劑

股票代碼:: ABEO
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

5.94 USD (-0.75%)

收盤價

最後更新: 2026年8月17日

324M USD

市值

股價為何變動

As of Aug 17, 2026, ABEO closed down 0.75% at $5.94. No new same-company headline was identified in the current news window.

公司概覽

Cell and Gene Therapy Company

Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.

ZEVASKYN

ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform.

ABO-701

ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.